Robert A. Palermo
Greater Baltimore Medical Center
4 Papers
160 Citations
Robert A. Palermo is an academic researcher from Greater Baltimore Medical Center. The author has contributed to research in topics: Head and neck squamous-cell carcinoma & Cancer. The author has an hindex of 4, co-authored 4 publications.
Chat about Author
Papers
Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas.
Ahmad R. Sedaghat,Zhe Zhang,Shahnaz Begum,Robert A. Palermo,Simon R. Best,Karen Ulmer,Marshall A. Levine,Eva S. Zinreich,Barbara Messing,Dorothy Gold,Annie A. Wu,Kevin J. Niparko,Jeanne Kowalski,Richard M. Hirata,Richard M. Hirata,John R. Saunders,John R. Saunders,William H. Westra,Sara Isabel Pai +18 more
TL;DR: Clinical outcomes with HPV status for patients with oropharyngeal carcinomas who were uniformly treated with a concurrent chemoradiation treatment protocol are correlated.
160
The effect of amifostine on submandibular gland histology after radiation.
Jacqueline C. Junn,James J. Sciubba,Justin A. Bishop,Eva S. Zinreich,Mei Tang,Marshall A. Levine,Robert A. Palermo,Carole Fakhry,Ray G. Blanco,John R. Saunders,Joseph A. Califano,Joseph A. Califano,Patrick K. Ha,Patrick K. Ha +13 more
TL;DR: In this article, the effects of amifostine on submandibular gland histology in patients receiving chemoradiation therapy were evaluated in head and neck squamous cell carcinoma patients.
Pathologic features associated with resolution of complex atypical hyperplasia and grade 1 endometrial adenocarcinoma after progestin therapy.
Camille C. Gunderson,Sonia Dutta,Amanda Nickles Fader,Kruti P. Maniar,Niloo Nasseri-Nik,Robert E. Bristow,Teresa Delp Diaz-Montes,Robert A. Palermo,Robert J. Kurman +8 more
TL;DR: In women with CAH or WDC, the overall response rate to progestin therapy was 65%; pre-treatment estrogen/progesterone receptor status did not predict response to treatment.
Genomic alterations in human epidermal growth factor receptor 2 (HER2/ERBB2) in head and neck squamous cell carcinoma.
Christine H. Chung,Alexis Germain,Rathan M. Subramaniam,Andreas M. Heilmann,Kyle Fedorchak,Siraj M. Ali,Vincent A. Miller,Robert A. Palermo,Carole Fakhry +8 more
TL;DR: Despite recent advances, survival outcomes for those with metastatic or recurrent head and neck squamous cell carcinoma have remained poor and novel approaches should be investigated to improve outcomes.